Ultrasound‐Induced Synchronized Neural Activities at 40 Hz and 200 Hz Entrained Corresponded Oscillations and Improve Alzheimer's Disease Memory
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70351 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Jiamin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical Engineering, Yanshan University, Qinhuangdao, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Memory Disorders, Brain Waves, CA1 Region, Hippocampal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Provincial Central Guidance Local Science and Technology Development Project, National Natural Science Foundation of China, Natural Science Foundation of Hebei Province.
Themen: Demenz
Abstract (Originalsprache)
Aims
Neurological diseases like Alzheimer's disease (AD) with cognitive deficits show impaired theta, gamma, and ripple bands. Restoring these oscillations may be crucial for rescuing cognitive functions. Low‐intensity transcranial ultrasound stimulation (TUS), a noninvasive neuromodulation method, offers high spatial resolution and deep penetration. However, it remains unclear how 40 Hz and 200 Hz TUS may improve memory in AD by regulating hippocampal oscillations.
Methods
We applied 40 Hz and 200 Hz TUS to the CA1 region of AD mice, performing memory assessments and CA1 electrophysiology recordings simultaneously.
Results
Our results showed that both 40 Hz and 200 Hz TUS significantly improved memory performance in AD mice by targeting the dorsal hippocampus and increasing power in corresponding frequency bands. Specifically, 40 Hz TUS enhanced gamma and ripple bands, while 200 Hz TUS strongly affected both. This enhancement increased during stimulation and persisted 5 days poststimulation. Improved coupling between theta and gamma oscillations indicated better hippocampal coordination with other brain regions. Additionally, 40 Hz TUS raised sharp wave ripple (SPW‐Rs) incidence, and 200 Hz TUS increased both SPW‐R incidence and duration, contributing to memory improvement. Behavioral performance significantly improved with TUS at both frequencies.
Conclusion
Ultrasound‐induced synchronized neural activities at 40 Hz and 200 Hz entrained corresponding oscillations and improved memory in Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Electrical Engineering, Yanshan University, Qinhuangdao, China.
- Key Laboratory of Intelligent Rehabilitation and Neuromodulation of Hebei Province, Yanshan University, Qinhuangdao, China.
- Guangdong Artificial Intelligence and Digital Economy Laboratory (Guangzhou), Guangzhou, China.
- School of Automation Science and Engineering, South China University of Technology, Guangzhou, China.
- Neuroscience Institute, NYU Langone Health, New York, New York, USA.
ORCID-Profile: Yi Yuan
Förderung
- Hebei Provincial Central Guidance Local Science and Technology Development Project
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province
Zitieren
APA
Chen, J., Wang, X., Li, X., Li, X., Zhang, Y., & Yuan, Y. (2025). Ultrasound‐Induced Synchronized Neural Activities at 40 Hz and 200 Hz Entrained Corresponded Oscillations and Improve Alzheimer's Disease Memory. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70351
Vancouver
Chen J, Wang X, Li X, Li X, Zhang Y, Yuan Y. Ultrasound‐Induced Synchronized Neural Activities at 40 Hz and 200 Hz Entrained Corresponded Oscillations and Improve Alzheimer's Disease Memory. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70351
BibTeX
@article{Chen2025,
author = {Chen, Jiamin and Wang, Xingran and Li, Xin and Li, Xiaoli and Zhang, Yiyao and Yuan, Yi},
title = {Ultrasound‐Induced Synchronized Neural Activities at 40 Hz and 200 Hz Entrained Corresponded Oscillations and Improve Alzheimer's Disease Memory},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70351}
}
EUVIMED